A*STAR Bioprocessing Technology Institute (A*STAR BTI)

A technique to generate antibodies that can help strengthen natural immune responses to cancer and leukemia has been developed

SynLinker offers a better way to design fusion protein drugs

The function of mature B cells is regulated by a small genomic cluster called mir-17-92

A protein produced by cells in response to stress can improve the production of biological medicines

Examining the intermediate stages of antibody purification provides
insight into the manufacture of safer biopharmaceuticals at lower cost

To produce
mesenchymal stem cells in large numbers will require careful tuning of their
growth media

A tool for isolating progenitor cells from human heart tissue could pave the way for cardiac cell therapy

A standard purification process changes the structure of antibodies — and then changes them back

Self-cleaving peptides are key for easy and efficient monoclonal antibody production

The immune system relies on an enzyme called Bruton’s tyrosine kinase to sense nucleic acids from pathogens

Researchers at A*STAR are mass-producing stem cells to satisfy the demands of regenerative medicine

Insight into a molecular mechanism for regulating blood sugar could enhance our understanding of diabetes